InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,841.47
(
-0.02%
)
US TECH 100
19,675.20
(
0.20%
)
Dow Jones
43,239.05
(
0.37%
)
Brent Oil
74.23
(
0.01%
)
Bitcoin
66,920.51
(
-1.03%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mitcheroo

Send PM Follow Ignore
Followers 22
Posts 1215
Boards Moderated 0
Alias Born 02/10/2005

mitcheroo

Re: opportunityknocking post# 25720

Saturday, 02/20/2010 1:37:01 PM

Saturday, February 20, 2010 1:37:01 PM

Post# of 30387
I would like to see a question about potential treatment applications, like complexing the RECAF antibody with a chemotherapeutic agent or radionucliide.

How much work or brainstorming has been directed toward that end? What's the current thinking on its likely feasibility? Do the current Abbott and Inverness licenses cover that aspect?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up